#news #biotech After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO .After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO
badams
Thu, 01/21/2021 – 04:31

from FierceBiotech: Biotech https://ift.tt/393bmOm